FDA Removes BPC 157, TB 500 and 10 More Peptides from Category 2 (April 2026) EvexiPEL Has It: The Patented Pellet Evexias Medical Center BPC 157 Keifei Pharma Keifei Pharma The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptide Therapy Vita 10 Therapy Bpc 157, Tb500, & Ghk cu Peptide, Color : Transparent at Rs 12000 in Nagpur ID: 8251245